{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.571","meta":{"versionId":"5","lastUpdated":"2019-03-02T01:00:10.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.571","version":"20190302","name":"Estrogen Receptor or Progesterone Receptor Positive Breast Cancer","status":"active","date":"2019-03-02T01:00:10-05:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://www.ama-assn.org/go/cpt","version":"2021","concept":[{"code":"3315F","display":"Estrogen receptor (ER) or progesterone receptor (PR) positive breast cancer (ONC)"}]}]},"expansion":{"identifier":"urn:uuid:b7da53ed-06bc-40c7-b156-1b906a5b3602","timestamp":"2022-06-10T07:29:11-04:00","total":1,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"3315F","display":"Estrogen receptor (ER) or progesterone receptor (PR) positive breast cancer (ONC)"}]}}